Abionyx Pharma annual capital expenditures (capex)
2019
2020
2021
2022
2023
2024
2025
Abionyx Pharma Capital Expenditures (CapEx) Growth & History (ABNX)
Abionyx Pharma's capital expenditures (capex) was €242,000 for fiscal 2025.
View full Abionyx Pharma company overviewAbionyx Pharma annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €242,000 | €174,000 | +255.88% |
| 2024 | 2024-12-31 | €68,000 | −€36,000 | −34.62% |
| 2023 | 2023-12-31 | €104,000 | −€61,000 | −36.97% |
| 2022 | 2022-12-31 | €165,000 | −€1,000 | −0.60% |
| 2021 | 2021-12-31 | €166,000 | €63,000 | +61.17% |
| 2020 | 2020-12-31 | €103,000 | €103,000 | — |
| 2019 | 2019-12-31 | €0 | — | — |
Abionyx Pharma capital expenditures (capex) trends
Over the last five fiscal years, Abionyx Pharma's capital expenditures (capex) increased from €103,000 to €242,000, a change of €139,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company official filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Abionyx Pharma source filings ↗